We observed a broad distribution of the fibroblast growth factor receptors FGFR1, FGFR2 and FGFR3 fusions—in particular FGFR3–TACC3 fusions—across eight of the 20 tumour types analysed (Fig. 1). Here, FGFR3 is linked to neoplasm.